Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Donald Schmid to Humans

This is a "connection" page, showing publications Donald Schmid has written about Humans.

 
Connection Strength
 
 
 
0.059
 
  1. Levin MJ, Weinberg A, Schmid DS. Herpes Simplex Virus and Varicella-Zoster Virus. Microbiol Spectr. 2016 06; 4(3).
    View in: PubMed
    Score: 0.013
  2. Levin MJ, DeBiasi RL, Bostik V, Schmid DS. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. J Infect Dis. 2008 Nov 15; 198(10):1444-7.
    View in: PubMed
    Score: 0.008
  3. Levin MJ, Ginde AA, Schmid DS, Lang N, Canniff J, Schwartz RS, Weinberg A. Effect of high dose vitamin D supplementation on subsequent immune responses to administration of the live herpes zoster vaccine to long-term care residents. Vaccine. 2024 04 02; 42(9):2278-2281.
    View in: PubMed
    Score: 0.005
  4. Weinberg A, Scott Schmid D, Leung J, Johnson MJ, Miao C, Levin MJ. Predictors of 5-Year Persistence of Antibody Responses to Zoster Vaccines. J Infect Dis. 2023 11 11; 228(10):1367-1374.
    View in: PubMed
    Score: 0.005
  5. Bubak AN, Beseler C, Como CN, Coughlan CM, Johnson NR, Hassell JE, Burnet AM, Mescher T, Schmid DS, Coleman C, Mahalingam R, Cohrs RJ, Boyd TD, Potter H, Shilleh AH, Russ HA, Nagel MA. Amylin, Aß42, and Amyloid in Varicella Zoster Virus Vasculopathy Cerebrospinal Fluid and Infected Vascular Cells. J Infect Dis. 2021 04 08; 223(7):1284-1294.
    View in: PubMed
    Score: 0.004
  6. Dutmer CM, Asturias EJ, Smith C, Dishop MK, Schmid DS, Bellini WJ, Tirosh I, Lee YN, Notarangelo LD, Gelfand EW. Late Onset Hypomorphic RAG2 Deficiency Presentation with Fatal Vaccine-Strain VZV Infection. J Clin Immunol. 2015 Nov; 35(8):754-60.
    View in: PubMed
    Score: 0.003
  7. Sabry A, Hauk PJ, Jing H, Su HC, Stence NV, Mirsky DM, Nagel MA, Abbott JK, Dragone LL, Armstrong-Wells J, Curtis DJ, Cohrs R, Schmid DS, Gilden D, Gelfand EW. Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency. J Allergy Clin Immunol. 2014 Apr; 133(4):1225-1227.
    View in: PubMed
    Score: 0.003
  8. Nagel MA, Russman AN, Feit H, Traktinskiy I, Khmeleva N, Schmid DS, Skarf B, Gilden D. VZV ischemic optic neuropathy and subclinical temporal artery infection without rash. Neurology. 2013 Jan 08; 80(2):220-2.
    View in: PubMed
    Score: 0.003
  9. Tsai J, Cohrs RJ, Nagel MA, Mahalingam R, Schmid DS, Choe A, Gilden D. Reactivation of type 1 herpes simplex virus and varicella zoster virus in an immunosuppressed patient with acute peripheral facial weakness. J Neurol Sci. 2012 Feb 15; 313(1-2):193-5.
    View in: PubMed
    Score: 0.002
  10. Birlea M, Arendt G, Orhan E, Schmid DS, Bellini WJ, Schmidt C, Gilden D, Cohrs RJ. Subclinical reactivation of varicella zoster virus in all stages of HIV infection. J Neurol Sci. 2011 May 15; 304(1-2):22-4.
    View in: PubMed
    Score: 0.002
  11. Blumenthal DT, Shacham-Shmueli E, Bokstein F, Schmid DS, Cohrs RJ, Nagel MA, Mahalingam R, Gilden D. Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF. Neurology. 2011 Feb 01; 76(5):484-5.
    View in: PubMed
    Score: 0.002
  12. Haug A, Mahalingam R, Cohrs RJ, Schmid DS, Corboy JR, Gilden D. Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature. J Neurol Sci. 2010 May 15; 292(1-2):85-8.
    View in: PubMed
    Score: 0.002
  13. Young-Barbee C, Hall DA, LoPresti JJ, Schmid DS, Gilden DH. Brown-Séquard syndrome after herpes zoster. Neurology. 2009 Feb 17; 72(7):670-1.
    View in: PubMed
    Score: 0.002
  14. Cohrs RJ, Mehta SK, Schmid DS, Gilden DH, Pierson DL. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J Med Virol. 2008 Jun; 80(6):1116-22.
    View in: PubMed
    Score: 0.002
  15. Gottlieb SL, Douglas JM, Foster M, Schmid DS, Newman DR, Baron AE, Bolan G, Iatesta M, Malotte CK, Zenilman J, Fishbein M, Peterman TA, Kamb ML. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis. 2004 Sep 15; 190(6):1059-67.
    View in: PubMed
    Score: 0.001
  16. Gottlieb SL, Douglas JM, Schmid DS, Bolan G, Iatesta M, Malotte CK, Zenilman J, Foster M, Barón AE, Steiner JF, Peterman TA, Kamb ML. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis. 2002 Nov 15; 186(10):1381-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)